Routine care and outcome of patients with locally advanced, inoperable (LAPC) and metastatic (MPC) pancreatic carcinoma Data from the Tumor Registry Pancreatic Cancer (TPK)

被引：0
|
作者：
Potthoff, K. [1 ]
Hegewisch-Becker, S. [2 ]
von der Heyde, E. [3 ]
Heinemann, V [4 ]
Hof, A. [1 ]
Binninger, A. [1 ]
Glasstetter, M. [1 ]
Jaenicke, M. [1 ]
Buerkle, D. [5 ]
Doerfel, S. [6 ]
Mohm, J. [7 ]
Marschner, N. [8 ]
机构：
[1] iOMEDICO, Freiburg, Germany
[2] Hamatol Onkol Praxis Eppendorf HOPE, Hamburg, Germany
[3] Onkol Schwerpunktpraxis, Hannover, Germany
[4] Klinikum Univ Munchen, Med Klin 3, Campus Grosshadern, Munich, Germany
[5] Zentrum Ambulante Onkol, Schorndorf, Germany
[6] Onkozentrum Dresden Freiberg, Dresden, Germany
[7] Onkol Gemeinschaftspraxis, Dresden, Germany
[8] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P691
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Characteristics of Patients with locally advanced or metastatic Pancreatic Cancer and more than one Year of Survival from the Start of Second-line Therapy - Data from the Pancreatic Cancer Clinical Tumor Registry (TPK)
    Potthoff, K.
    Hegewisch-Becker, S.
    von der Heyde, E.
    Nusch, A.
    Binninger, A.
    Wetzel, N.
    Jaenicke, M.
    Reiser, M.
    Wolf, T.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 258 - 258
  • [2] 2nd-line treatment and outcome in patients with locally advanced or metastatic pancreatic cancer - data from the TPK clinical cohort study
    Hegewisch-Becker, S.
    Lerchenmueller, C.
    Reiser, M.
    Zacharias, S.
    Hamm, D.
    Jaenicke, M.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 35 - 35
  • [3] Real-life treatment of patients with advanced pancreatic cancer in Germany - data from the clinical registry pancreatic cancer (TPK)
    Hegewisch-Becker, S.
    Hofheinz, R.
    Hartmann, H.
    Kopfmann, S.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 86 - 86
  • [4] Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors
    Sezgin, C
    Karabulut, B
    Uslu, R
    Sanli, UA
    Goksel, G
    Yuzer, Y
    Goker, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (12) : 1486 - 1492
  • [5] Progression-free and overall survival of patients with advanced or metastatic pancreatic cancer in German outpatient centers - first outcome data from the clinical TPK Registry
    Hegewisch-Becker, S.
    Hofheinz, R.
    Wolf, T.
    Aldaoud, A.
    Harde, J.
    Kopfmann, S.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 : 5 - 5
  • [6] Outcomes of patients with locally advanced or metastatic pancreatic cancer treated with different sequential treatment strategies -data from the prospective Tumour Registry Pancreatic Cancer
    Hegewisch-Becker, Susanna
    Reiser, Marcel
    Doerfel, Steffen
    Lerchenmueller, Christian
    Linde, Hartmut
    Wolf, Thomas
    Binninger, Adrian
    Wetzel, Natalie
    Jaenicke, Martina
    Marschner, Norbert
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 81 - 81
  • [7] Neoadjuvant Chemoradiation in patients with locally advanced inoperable pancreatic cancer
    Combs, S. E.
    Habermehl, D.
    Lausecker, M.
    Kessel, K.
    Roeder, F.
    Buechler, M. W.
    Werner, J.
    Debus, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 39 - 40
  • [8] Outcomes of patients with locally advanced or metastatic pancreatic cancer treated with different sequential treatment strategies - data from the prospective Tumour Registry Pancreatic Cancer
    Hegewisch-Becker, S.
    Reiser, M.
    Doerfel, S.
    Lerchenmueller, C.
    Linde, H.
    Wolf, T.
    Binninger, A.
    Wetzel, N.
    Jaenicke, M.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 220 - 220
  • [9] Outcome of patients with metastatic or locally advanced unresectable colorectal cancer in routine care
    Burkart, Christof
    Budach, Wilfried
    Hartmann, Joerg Thomas
    Klump, Bodo
    Pereira, Philippe
    Teichmann, Reinhard
    Bokemeyer, Carsten
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [10] Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC)
    James, Edward Samuel
    Yao, Xiaopan
    Cong, Xiangyu
    Li, Jia
    Hahn, Carol
    Kaley, Kristin
    Kortmansky, Jeremy S.
    Fischbach, Neal A.
    Chang, Bryan William
    Salem, Ronald R.
    Cha, Charles
    Stein, Stacey
    Hochster, Howard S.
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345